Byron Hoogwerf, MD, FACP, CDE, FACE, is a graduate of Calvin College in Grand Rapids, Mich., and the University of Minnesota Medical School in Minneapolis. He completed his residency at Hennepin County Medical Center in Minneapolis and his endocrinology fellowship training at the University of Minnesota. He was on the faculty at the University of Minnesota for 4 years before joining the Cleveland Clinic in Ohio for 23 years. He has been a full-time employee of Eli Lilly and Co. as a clinical research physician since October 2008.
Dr. Hoogwerf's career has comprised clinical practice and clinical research in the areas of diabetes and cardiovascular risk reduction. He has been involved in a number of multicenter clinical trials, including the Lipid Research Clinics—Coronary Primary Prevention Trial (LRC-CPPT), Post Coronary Artery Bypass Graft (Post-CABG), Action to Control Cardiovascular Risk in Diabetes (ACCORD), Heart Outcomes Prevention Evaluation (HOPE), Heart Outcomes Prevention Evaluation—The Ongoing Outcomes (HOPE-TOO), Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM), Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET), and Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND).
While at the Cleveland Clinic, he served as chairman of endocrinology, program director for the internal medicine residency program, and program director for the endocrinology fellowship program. He has been involved in the Diabetes Association of Greater Cleveland as a board member, president of the board, and member of multiple committees. He has also been active in the American Diabetes Association (ADA), including serving for 3 years on its national board of directors. He has been chairman of the ADA Council on Nutrition, chairman of the ADA Publications Policy Committee, and a member of the ADA Clinical Practice Committee and several of the organization's nutrition guidelines writing groups. He has written more than 200 invited and reviewed publications and book chapters.
Ruth Lindquist, PhD, RN, ACNS-BC, FAAN, is a professor of nursing at the University of Minnesota in Minneapolis and a research consultant to the Women's Heart Health Program of the Minneapolis Heart Institute/Minneapolis Heart Institute Foundation. She is an adjunct faculty member for the graduate minor program of the University of Minnesota's Center for Spirituality and Healing.
Dr. Lindquist has co-edited three editions of Complementary and Alternative Therapies: A Guide for Nurses. Her research focuses on the use of complementary therapies, including relaxation techniques, acupuncture, and mindfulness meditation, in cardiovascular patients to reduce stress, promote health, and improve health-related quality of life. She has used evidence-based complementary therapies in her practice throughout her career, including acute and critical coronary care, and in the context of the women's cardiac support group that she facilitates. She has worked with other investigators to document, through a national survey study, interest in and personal and professional use of complementary and alternative therapies in the practice of critical care nurses.
Carrie S. Swift, MS, RD, BC-ADM, CDE, was the Diabetes Spectrum associate editor in charge of coordinating this From Research to Practice section.
